News
The company will use the funds to grow its technology platform and open new clinics.
Researchers claim their invention offers a cost-effective and faster way to do single-cell analysis.
The new model is designed for scalability, allowing Aidoc to develop and refine AI solutions quicker and permit radiologists to make decisions using real-time data.
The aim is to offer a broader range of personalized treatment options to patients.
The firings included 20 individuals in the FDA's Office of Neurological and Physical Medicine Devices.
The company has received 12 US FDA approvals.
The company offers services like sperm cryopreservation, fertility testing, testosterone treatments, and vasectomies.
The aim of the partnership is to research how AI can help predict cancer progression.
The announcement comes just three months after XRHealth announced it acquired cognitive training VR platform NeuroReality and its assets.
The company will use the funds to expand its team and hasten its product direction as demand for its offering accelerates.